14-3-3 Protein, neuron-specific enolase, and S-100 protein in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease

Dementia and Geriatric Cognitive Disorders

Volumn 10, Issue 1, 1999, Pages 40-46

  Beaudry, P ^a   Cohen, P ^a   Brandel, J P ^b   Delasnerie Laupretre N ^b   Richard, S ^c   Launay, J M ^a,d   Laplanche, J L ^a,d  

^a HÔPITAL LARIBOISIÈRE   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c INSTITUT PASTEUR   (France)

^d Faculte de Pharmacie   (France)

Author keywords

14 3 3 Protein; Cerebrospinal fluid; Creutzfeldt Jakob disease; Neuron specific enolase; S 100 protein

Indexed keywords

BIOLOGICAL MARKER; NEURON SPECIFIC ENOLASE; PRION PROTEIN; PROTEIN S 100;

ARTICLE; CEREBROSPINAL FLUID; CEREBROSPINAL FLUID ANALYSIS; CREUTZFELDT JAKOB DISEASE; DIAGNOSTIC TEST; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN CEREBROSPINAL FLUID LEVEL;

14-3-3 PROTEINS; ADULT; CREUTZFELDT-JAKOB SYNDROME; FEMALE; HUMANS; IMMUNOCHEMISTRY; MALE; PHOSPHOPYRUVATE HYDRATASE; PREDICTIVE VALUE OF TESTS; PROTEINS; S100 PROTEINS; TYROSINE 3-MONOOXYGENASE;

EID: 0032889062     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000017095     Document Type: Article

References (29)

1. Masters CL, Harris JO, Gajdusek DC, Gibbs CJ, Bernouilli C, Asher DM: Creutzfeldt-Jakob disease: Patterns worldwide occurrence and the significance of familial and sporadic clustering. Ann Neurol 1979;5:177-188.
2. Chapman J, Brown P, Goldfarb LG, Arlazaroff A, Gajdusek DC, Korczyn AD: Clinical heterogeneity and unusual presentation of Creutzfeldt-Jakob disease in Jewish patients with the PRNP codon 200 mutation. J Neurol Neurosurg Psychiatry 1993;56:1109-1112.
3. Kawasaki K, Wakabayashi K, Kawakami A, Higuchi M, Kitamoto T, Tsuji S, Takashi H: Thalamic form of Creutzfeld-Jakob disease or fatal insomnia? Report of a sporadic case with normal prion protein genotype. Acta Neuropathol (Berl) 1997;93:317-322.
4. Bortone E, Bettoni L, Giorgi C, Terzano MG, Trabatonni GR, Mancia D: Reliability of EEG in the diagnosis of Creutzfeldt-Jakob disease. Electroencephalogr Clin Neurophysiol 1994; 90:323-330.
5. Brown P, Gibbs CJ Jr, Rodgers-Jackson P, Asher P, Sulima MP, Bacote A, Goldfarb LG, Gajdusek DC: Human spongiform encephalopathy: The National Institute of Health series of 300 cases of experimental transmitted disease. Ann Neurol 1994;35:513-529.
6. Will RG, Ironside J, Zeidler M, Cousens SN, Estibeiro K, Alperovitch A, Poser S, Pocchiari M, Hofman A, Smith PG: A new variant of Creutzfeldt-Jakob disease in the UK. Lancet 1996;347:921-925.
7. Bruce ME, Will RG, Ironside JW, McConnell I, Drummond D, Suttie A, McCardle L, Chree A, Hope J, Birkett C, Cousens S, Fraser H, Bostock CJ: Transmissions to mice indicate that 'new variant' CJD is caused by the BSE agent. Nature 1997;388:498-501.
8. Ironside JW, Bell J: Pathology of prion diseases; in Collinge J, Palmer MS (eds): Prion Diseases. Oxford, Oxford University Press, 1997, pp 57-87.
9. Harrington MG, Merrill CR, Asher DM, Gajdusek DC: Abnormal proteins in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. N Engl J Med 1986;315:279-283.
10. Jimi T, Wakayama Y, Shibuya S, Nakata H, Tomaru T, Takahashi Y, Kosaka K, Asano T, Kato K: High levels of nervous system-specific proteins in cerebrospinal fluid in patients with early stage Creutzfeldt-Jakob disease. Clin Chim Acta 1992;211:37-46.
11. Zerr I, Bodemer M, Räcker S, Grosche S, Poser S, Kretzschmar H, Weber T: Cerebrospinal fluid concentration of neuron-specific enolase in diagnosis of Creutzfeldt-Jakob disease. Lancet 1995;345:1609-1610.
12. Zerr I, Bodemer M, Otto M, Poser S, Windl O, Kretzschmar H, Gefeller O, Weber T: Diagnosis of CJD by two-dimensional gel electrophoresis of CSF. Lancet 1996;348:846-849.
13. Hsich G, Kenney K, Gibbs C, Lee K, Harrington M: The 14-3-3 brain protein in CSF as a marker for transmissible spongiform encephalopathies. N Engl J Med 1996;335:924-930.
14. Lee KH, Harrington MG: Premortem diagnosis of Creutzfeldt-Jakob disease by cerebrospinal fluid analysis. Lancet 1996;348:887.
15. Otto M, Wiltfang J, Tumani H, Zerr I, Lantsch M, Kornhuber J, Weber T, Kretzschmar HA, Poser H: Elevated levels of tau-protein in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. Neurosci Lett 1997;225:210-212.
16. Nooijen PTGA, Schooderwald HC, We vers RA, Hommes OR, Lamers KJB: Neuron-specific enolase, S-100 protein, myelin basic protein and lactate in CSF in dementia. Dement Geriatr Cogn Disord 1997;8:169-173.
17. Zerr I, Bodemer M, Gefeller O, Otto M, Poser S, Wiltfang J, Windl O, Kretzschmar HA, Weber T: Detection of 14-3-3 protein in the cerebrospinal fluid supports the diagnosis of Creutzfeldt-Jakob disease. Ann Neurol 1998; 43:32-40.
18. Otto M, Stein H, Szudra A, Zerr I, Bodemer M, Gefeller O, Poser S, Kretzschmar HA, Mäder M, Weber T: S-100 protein concentration in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. J Neurol 1997;244:566-570.
19. Otto M, Wiltfang J, Schütz E, Zerr I, Otto A, Pfahlberg A, Gefeller O, Uhr M, Giese A, Weber T, Kretzschmar HA, Poser S: Diagnosis of Creutzfeldt-Jakob disease by measurement of S100 protein in serum: Prospective case-control study. BMJ 1998;316:577-582.
20. Palmer S, Dryden A, Hughes T, Collinge J: Homozygous prion protein predisposes to sporadic Creutzfeldt-Jakob disease. Nature 1991; 352:340-341.
21. Laplanche JL, Delasnerie-Lauprêtre N, Brandel JP, Chatelain J, Beaudry P, Alpérovitch A, Launay JM: Molecular genetics of prion diseases in France. Neurology 1994;44:2347-2351.
22. Parchi P, Castellani R, Capellari S, Ghetti B, Young K, Chen S, Farlow M, Dickson D, Sima A, Trojanowski J, Petersen R, Gambetti P: Molecular basis of phenotypic variability in sporadic Creutzfeldt-Jakob disease. Ann Neurol 1996;39:767-778.
23. Zeidler M, Stewart GE, Barraclough CR, Bateman DE, Bates D, Burn DJ, Colchester AC, Durward W, Fletcher NA, Hawkins SA, Mackenzie JM, Will RG: New variant Creutzfeldt-Jakob disease: Neurological features and diagnostic tests. Lancet 1997;350:903-907.
24. Moussavian M, Potolicchio S, Jones R: The 14-3-3 brain protein and transmissible spongiform encephalopathies. N Engl J Med 1997;336: 873-874.
25. Lamers KJB, Van Engelen BGM, Gabreels FJM, Hommes OR, Borm GF, Wevers RA: Cerebrospinal neuron-specific enolase, S-100 and myelin basic protein in neurological disorders. ActaNeurol Scand 1995;92:247-251.
26. Hsiao K, Baker HF, Crow TJ: Linkage of prion protein missense variant to Gerstmann-Sträussler syndrome. Nature 1989;338:342-345.
27. Rosenmann H, Meiner Z, Kahana E, Halimi M, Lenetsky E, Abramsky O, Gabizon R: Detection of 14-3-3 in the CSF of genetic Creutzfeldt-Jakob disease. Neurology 1997;49:593-595.
28. Will RG, Zeidler M, Brown P, Harrington M, Lee KH, Kenney KL: Cerebrospinal fluid test or new variant Creutzfeldt-Jakob disease. Lancet 1996;348:955.
29. Persson L, Hardemark HG, Gustafsson J, Rundström G, Mendel-Hartvig I, Esscher T, Pahlman S: S-100 protein and neuron-specific enolase in cerebrospinal fluid and serum: Markers of cell damage in human central nervous tissue. Stroke 1987;18:911-918.